logo

April 2017 #urojc summary: Is SABR a viable therapeutic option for managing renal tumors in patients deemed unsuitable for surgery? In April 2017, the International Twitter-based U[...]
Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
In this issue, Simhan et al. [1] use the Surveillance, Epidemiology, and End Results (SEER) database to compare outcomes of nephron-sparing and radical extirpative therapy for uppe[...]
Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma Jay Simhan, Marc C. Smaldone, Brian L. Egleston*, Da[...]
The current article by Sun et al. [1] representing a number of institutions involved in prostate cancer treatment provision is thought-provoking and hypothesis-generating. The auth[...]
“It’s a gold mine!” said someone to me once about the Surveillance, Epidemiology, and End Results (SEER). Most of you are probably aware of the existence of this large observationa[...]